HPV viral load determination during pregnancy as a possible cervical cancer risk

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 29-38

  Bandyopadhyay, S ^a   Chatterjee, Ramdas ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cervical cancer; HPV; PCR; Pregnancy; Viral load

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HUMAN; IMMUNE DEFICIENCY; MALIGNANT TRANSFORMATION; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADULT; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD;

EID: 33646101822     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parkin D.M., Pisani P., Ferlay J.: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 54: 594-606, 1993.
2. Bosch F.X., Manos M.M., Munoz M.M., et al.: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87: 796-802, 1995.
3. Cuzick J., Terry G., Ho L., Hollingworth T., Anderson M.: Human papillomavirus type 16 in cervical smears as predictor of high grade cervical intraepithelial neoplasia. Lancet. 339: 959-960, 1992.
4. Ho Gy., Palan P.R., Basu J., et al.: Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int. J. Cancer 78: 594-599, 1998.
5. Ylitalo N., Sorensen P., Josefsson A., et al.: Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int. J. Cancer 81: 357-365, 1999.
6. Moodley M., Moodley J., Chetty R., Herrington C.S.: The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int. J. Gynecol. Cancer 13: 103-110, 2003.
7. Purtilo P.T., Hallgren H.M., Yunis E.J.: Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy. Lancet. I: 769-771, 1972.
8. Yu V.Y.H., Waller C.A., Maclennan I.C.M., Baum J.D.: Lymphocyte reactivity in pregnant women and newborn infants. Brit. Med. J. I: 428-430, 1975.
9. Saiki R.K., Gelfand D.H., Stoffel S., et al.: Primer directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 239: 487-491, 1988.
10. Manos M.M., Ting Y., Wright D.K., et al.: The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In molecular Diagnostics of human cancer: Cancer cells Cold Spring Harbor, NY: Cold Spring Harbor Laboratory 7: 209-214, 1989.
11. Miller C.S., Zeuss C.S., White D.K.: Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridisation. Oral Surg. Oral Med. Oral Pathol. 77: 480-486, 1994.
12. Schlecht N.F., Trevisan A., Franco E.D., et al.: Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 103: 519-524, 2003.
13. van den Brule A.J., Walboomers J.M.M., de Maine M., Denemans P., Meijers C.H.L.M.: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal smears is associated with a history of cervical intraepithelial neoplasia, Int. J. Cancer 48: 404-408, 1990.
14. Wheeler C., Parmenter C.A., Hunt W.C., et al.: Determinants of genital human papillomavirus infection among cytologically normal women attending the University. Sex. Transm. Dis. 20: 286-289, 1993.
15. Hildesheim A., Gravitt P., Schiffmann M.H., et al.: Determinants of genital papillomavirus infection in low income women in Washington DC. Sex. Trans. Dis. 20: 279-285, 1993.
16. Eppel W., Worda C., Frigo P., Ulm M., Kucera E., Czerwenka K.: Human papillomavirus in the cervix and placenta. Obstet. Gynecol. 96: 337-341, 2000.
17. Tenti P., Zappatore R., Migliora P., et al.: Latent human papillomavirus infection in pregnant women at term: a case-control study. J. Infect. Dis. 176: 277-280, 1997.
18. Gopalkrishna V., Murthy N.S., Sharma J.K., et al.: Increased human papillomavirus infection with the increasing number of pregnancies in Indian women. J. Infect. Dis. 171: 254-255, 1995.
19. Muñoz N., Franceschi S., Bosetti C., et al.: Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, for the International Agency for Research on Cancer (IARC). Lancet. 359: 1093-1101, 2002.
20. Schneider A., Hotz M., Gissmann L.: Increased prevalence of human papillomavirus in the lower genital tract of pregnant women. Int. J. Cancer 40: 198-201, 1987.
21. Rando R.F., Lindheim S., Hasty L., Sedlacek T.V., Woodland M., Eder C.: Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am. J. Obstet. Gynecol. 161: 50-55, 1989.
22. Peng T.C., Searle C.P., Shah K.V., Repke J.T., Johnson T.R.B.: Prevalence of human papillomavirus infections in term pregnancy. Am. J. Perinatol. 7: 189-192, 1990.
23. Smith E.M., Johnson S.R., Jiang D., et al.: The association between pregnancy and human papillomavirus prevalence. Cancer Detect. Prev. 15: 397-402, 1991.
24. Kemp E.A., Hakenewerth A.M., Laurent S.L., Gravitt P.E., Stoerker J.: Human papillomavirus prevalence in pregnancy. Obstet. Gynecol. 79: 649-656, 1992.
25. de Roda Husman A.M., Walboomers J.M., Hopman E., et al.: HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR the age related pattern. J. Med. Virol. 46: 97-102, 1995.
26. Fife K.H., Katz B.P., Roush J., Handy V.D., Brown D.R., Hansell R.: Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am. J. Obstet. Gynecol. 174: 1487-1493, 1996.
27. Fife K.H., Katz B.P., Brizendine E.J., Brown D.R.: Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am. J. Obstet. Gynecol. 180: 1110-1114, 1999.
28. Cason J., Rice P., Best J.M.: Transmission of cervical cancer-associated human papillomaviruses from mother to child. Intervirology 41: 213-218, 1998.
29. Bandyopadhyay S., Sen S., Majumdar L., Chatterjee R.: Human papillomavirus infection among Indian mothers and their infants. APJCP. 4: 179-184, 2003.
30. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J., et al.: High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br. J. Cancer 87: 75-80, 2002.
31. Armbruster- Moraes E., Ioshimoto L.M., Leao E., Zugaib M.: Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol. Oncol. 54: 152-158, 1994.
32. Marco F.D., Carlo A.D., Poggiali F., Muller A., Marcante M.L.: Detection of HPV in genital condylomata: Correlation between viral load and clinical outcome. J. Exp. Clin. Cancer Res. 20: 377-383, 2001.
33. Josefsson A.M., Magnusson P.K., Ylitalo N., et al.: Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 355: 2194-2198, 2000.
34. Ylitalo N., Sorensen P., Jossefsson A.M. et al.: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 355(9222): 2194-2198, 2000.
35. Swan D.C., Tucker R.A., Tortolero -Luna G., et al.: Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37: 1030-1034, 1999.
36. Van duin M., Snijders P.J.F., Schrijnemakers H.F.J., et al.: Human papillomavirus 16 load in normal and abnormal cervical scrapes: as an indicator of CIN II/III and viral clearance. Int. J. Cancer 98: 590-595, 2002.